CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: Nitroglycerin in Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial of nitroglycerin in non-small cell lung cancer was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maastricht Radiation Oncology | Conditions: Non Small Cell Lung Cancer (NSCLC) | Phase 2 | Status: TERMINATED